Project Grant K24DA065778
Award Date 5/1/26
Completion Date 4/30/31
Dollars Obligated $218K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- Federal Grant Award Summary Award Overview The National Institute on Drug Abuse (NIDA) awarded a $193,751 Project Grant to the Trustees of Boston University under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 1, 2026, with completion expected by April 30, 2031. This Career Development Award supports research aimed at advancing the quality of care for Medicaid enrollees in outpatient substance use disorder (SUD) treatment facilities. The award funds a comprehensive training...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year award supports research to evaluate the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The research will deliver two primary...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $144,252 Project Grant to the University of Massachusetts Medical School beginning September 1, 2025, and concluding August 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Carreiro will develop and deliver mentoring and research training opportunities for early-career scientists within medical toxicology, focusing on personalized medicine approaches to substance use disorder (SUD). The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $399,600 to Brigham & Women's Hospital Inc. under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 15, 2025, through a Mentored Research Scientist Development Award (K01) mechanism. The award supports a five-year career development and research program under the principal investigator, Dr. Jason Brian Gibbons, Assistant Professor at the University of Colorado Anschutz Medical Campus. The...
- Federal Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. This mentored research career development award supports a mixed-methods study examining the impact of Massachusetts's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program—a statewide Medicaid initiative launched in 2022...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $193,180 Project Grant to Boston University (Trustees of Boston University, operating as Boston University Medical Campus) under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 15, 2026, with completion expected by February 28, 2031. This K01 Career Development Award funds research and mentorship training for Dr. Auty to become an independent investigator specializing in how Medicaid Managed Care (MMC)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $352,540 to the Children's Hospital of Philadelphia Research Institute under the Drug Use and Addiction Research Programs (CFDA 93.279) for a five-year project grant beginning August 1, 2025. This award supports a research initiative titled "The Adolescent Surgery Experience: Preoperative Anticipatory Guidance and Postoperative Opioid Misuse (POM)," which addresses the significant clinical problem of opioid...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded McLean Hospital a $386,640 Career Development Award (K23) under the Drug Use and Addiction Research Programs (CFDA 93.279) on March 1, 2026, with a completion date of February 28, 2031. The award provides targeted training and research support to Dr. Robyn Ellis to develop her capacity as an independent investigator conducting mechanistic clinical trials for individuals with co-occurring substance use disorder and...